Avandia FDA Restrictions for the Avandia Side Effects

This is common thing because in the clinical trials only small amount of people is treated with the drug and there is no mathematical possibility for all side effects to be present.

However, the most concerned thing to FDA is that many of the patients who are on Avandia therapy died from heart attack and stroke. The percent of people dying from these two complications is much higher as compared to the percent of people who do not take any drugs or medications.

Therefore, this statistic led to the logical conclusion that the drug is having something to do with this increased chance ofreceiving heart attack or stroke.

The most common side effects are headache, back pain, vomiting, stomach pain, blurred vision, tachycardia, difficulties catching your breath, swelling of the arms, legs, sweating; they are just a small fraction of these symptoms.

They contribute to worsening the patient’s life, when he/she is on a treatment with Avandia.

The other possible side effects are even worse. There is one of them, which is a potentially life-threatening complication - upper respiratory tract infection.

This infection is hard to be treated with ordinary antibiotics because there are many different microorganisms, which are present there. This makes this complication one of the worst.

The pharmaceutical company that produces this medicament was asked to make more clinical trials with impend team of doctors and scientists to examine the side effects of long treatment with Avandia.

Up to the point, they actually have results from these new clinical trials, FDA will have their restrictions up and running. These restrictions affect every patient that has diabetes type 2, and they use this drug as a medication of first choice.

Therefore, the doctors are forbidden to prescribe this drug. They cannot prescribe it to any patient that has small fluctuations in the sugar blood level.

However, there is an option for the people that have bad regulation of their sugar level. They could get the drug, if a doctor committee assesses that the coefficient benefit: risk is in favor of the benefit. Avandia fda restrictions will last till the new clinical trials end.